Devin Carty

Devin Carty has worked as a biologist and biochemist with NASA, built medical clinics in the jungles of the Congo, and pursued healthcare solutions as an entrepreneur, venture capitalist, and healthcare system operator.

Devin is the CEO for Martin Ventures, a healthcare-focused venture capital firm, where he leads the investment committee and provides oversight for 25 portfolio companies. Devin’s historical investments include AmericanWell (IPO), OneDrop (recapitalized by Bayer), Valify (acquired by HCA Healthcare), Trilliant Health (recapitalized by Primus Capital), Jvion (acquired by JMI Equity), Avizia (acquired by AmericanWell), Healthcare Bluebook (acquired by Primus Capital), and Clockwise.MD (acquired by DocuTAP).

Devin has cofounded several companies including Wellvana Health, Trilliant Health, and Clariture Health.